MoneyWorks4Me

The company witnessed a 22.23% growth in the revenue at Rs. 50150.00 millions for the quarter ended December 2024 as compared to Rs. 41030.00 millions during the year-ago period.Profit for the quarter ended December 2024 rises by 78.75% to Rs. 8494.00  millions from Rs. 4752.00 millions.Operating profit for the quarter ended December 2024 rose to 14278.00 millions as compared to 8839.00 millions of corresponding quarter ended December 2023.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202412 202312 % Var 202412 202312 % Var 202403 202303 % Var
Sales 50150.00 41030.00 22.23 175525.00 143790.00 22.07 194838.00 169625.00 14.86
Other Income 2354.00 2276.00 3.43 6608.00 6843.00 -3.43 8623.00 5913.00 45.83
PBIDT 14278.00 8839.00 61.53 65278.00 51974.00 25.60 67887.00 48061.00 41.25
Interest 433.00 56.00 673.21 788.00 159.00 395.60 218.00 169.00 28.99
PBDT 13845.00 8783.00 57.63 64490.00 51815.00 24.46 67669.00 47892.00 41.29
Depreciation 2651.00 2464.00 7.59 7749.00 7294.00 6.24 9756.00 9232.00 5.68
PBT 11194.00 6319.00 77.15 56741.00 44521.00 27.45 57913.00 38660.00 49.80
TAX 2700.00 1567.00 72.30 15254.00 11449.00 33.23 14493.00 12532.00 15.65
Deferred Tax 137.00 -2.00 -6950.00 992.00 533.00 86.12 875.00 3891.00 -77.51
PAT 8494.00 4752.00 78.75 41487.00 33072.00 25.44 43420.00 26128.00 66.18
Equity 834.00 834.00 0.00 834.00 834.00 0.00 834.00 833.00 0.12
PBIDTM(%) 28.47 21.54 32.16 37.19 36.15 2.89 34.84 28.33 22.97
Peers
Company Name CMP
Sun Pharma. Inds. 1842.00
Dr. Reddys Labs. 1161.00
Cipla 1365.00
Lupin 2096.00
Zydus Lifesciences 1119.50
View more..